DeepMed Research

HOSPITAL CLINIC DE BARCELONA

🇪🇸Spain

Country: 🇪🇸Spain

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

Effect of Immunosuppression Drug Weaning on Hepatitis C Virus (HCV)-Induced Liver Damage After Liver Transplantation

Phase 2

Completed

Conditions: Hepatitis C Virus Infection
Liver Transplantation

Interventions: Procedure: Gradual immunosuppression drug withdrawal.

First Posted Date: 2008-04-29

Last Posted Date: 2013-12-20

Lead Sponsor: Hospital Clinic of Barcelona

Target Recruit Count: 34

Registration Number: NCT00668369

Locations: 🇪🇸
Hospital Clinic Barcelona, University of Barcelona, Barcelona, Spain

Intravenous Iron Versus Oral Iron for Severe Postpartum Anemia

Phase 4

Completed

Conditions: Anemia
Puerperal Disorders

Interventions: Drug: Iron sucrose
Drug: NaCl

First Posted Date: 2008-04-17

Last Posted Date: 2016-03-08

Lead Sponsor: Hospital Clinic of Barcelona

Target Recruit Count: 70

Registration Number: NCT00660933

Locations: 🇪🇸
Hospital Clínic of Barcelona, Barcelona, Spain

Metabolic Effects of Enfuvirtide in Healthy Volunteers

Phase 4

Completed

Conditions: HIV Infections

Interventions: Drug: Placebo
Drug: Enfuvirtide

First Posted Date: 2008-04-14

Last Posted Date: 2008-04-14

Lead Sponsor: Hospital Clinic of Barcelona

Target Recruit Count: 15

Registration Number: NCT00657761

Locations: 🇪🇸
Hospital Clinic, Barcelona, Spain

Efficacy of Pamidronate in the Treatment of Bone Loss Associated With Liver Transplant

Phase 4

Completed

Conditions: Bone Disease, Metabolic

Interventions: Drug: Placebo
Drug: Disodium pamidronate

First Posted Date: 2008-04-14

Last Posted Date: 2008-04-14

Lead Sponsor: Hospital Clinic of Barcelona

Target Recruit Count: 79

Registration Number: NCT00657852

Locations: 🇪🇸
Hospital Clinic i Provincial of Barcelona, Barcelona, Spain

Vaginal PROgesterone as Maintenance Treatment After an epISode of prEterm Labor (PROMISE Study)

Phase 4

Completed

Conditions: Threatened Premature Labor

Interventions: Drug: Progesterone
Drug: Placebo

First Posted Date: 2008-03-31

Last Posted Date: 2016-08-19

Lead Sponsor: Hospital Clinic of Barcelona

Target Recruit Count: 265

Registration Number: NCT00646802

Locations: 🇪🇸
Hospital Sant joan de Déu de Manresa, Manresa, Barcelona, Spain
🇪🇸
Institut Universitari Dexeus, Barcelona, Spain
🇪🇸
Hospital Virgen de la Macarena, Seville, Spain

and more 9 locations

Yunzhi as Dietary Supplement in Breast Cancer

Phase 4

Conditions: Breast Cancer

Interventions: Dietary Supplement: Yunzhi extract
Dietary Supplement: Placebo

First Posted Date: 2008-03-31

Last Posted Date: 2010-12-15

Lead Sponsor: Hospital Clinic of Barcelona

Target Recruit Count: 60

Registration Number: NCT00647075

Locations: 🇪🇸
Hospital Clinic, Barcelona, Spain
🇪🇸
Hospital Parc Tauli, Sabadell, Barcelona, Spain

Assessment Of the Safety and Benefit of Prospective Immunosuppressive Drug Withdrawal in Liver Transplantation and Prediction of Operational Tolerance

Phase 2

Conditions: Liver Transplantation

Interventions: Procedure: Gradual immunosuppression drug withdrawal

First Posted Date: 2008-03-31

Last Posted Date: 2011-04-20

Lead Sponsor: Hospital Clinic of Barcelona

Target Recruit Count: 80

Registration Number: NCT00647283

Locations: 🇪🇸
Hospital Clinic Barcelona, University of Barcelona, Barcelona, Spain

Strategies of Interruption/Reinitiation of Antiretroviral Therapy in HIV-Infected Patients With Lipodystrophy

Phase 4

Completed

Conditions: HIV-Associated Lipodystrophy Syndrome

Interventions: Drug: Standard continuous antiretroviral therapy
Drug: CD-4 guided therapy interruption
Drug: Viral load driven treatment interruption

First Posted Date: 2008-03-31

Last Posted Date: 2008-03-31

Lead Sponsor: Hospital Clinic of Barcelona

Target Recruit Count: 147

Registration Number: NCT00646984

Locations: 🇪🇸
Hospital Clinic of Barcelona, Barcelona, Spain

Pentoxifylline and Endometriosis

Phase 3

Completed

Conditions: Endometriosis-Associated Infertility

Interventions: Drug: placebo
Drug: pentoxifylline

First Posted Date: 2008-03-11

Last Posted Date: 2008-03-11

Lead Sponsor: Hospital Clinic of Barcelona

Target Recruit Count: 104

Registration Number: NCT00632697

Locations: 🇪🇸
Hospital Clinic, Barcelona, Spain

Terlipressin in Septic Shock in Cirrhosis

Phase 2

Completed

Conditions: Liver Cirrhosis
Septic Shock

Interventions: Drug: alpha adrenergic drugs
Drug: Terlipressin

First Posted Date: 2008-03-04

Last Posted Date: 2016-02-24

Lead Sponsor: Hospital Clinic of Barcelona

Target Recruit Count: 72

Registration Number: NCT00628160

Locations: 🇪🇸
Hospital Clinic Barcelona, Barcelona, Catalonia, Spain

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy